Abstract
The incidence and type of allergic reactions to antilymphoblast globulin (ALG) and their relationship to skin testing, histamine release, and serum levels of ALG and anti-ALG antibodies were studied prospectively in 50 patients receiving high-dose ALG therapy intravenously for the first two weeks after renal transplantation. No clinically apparent allergic reactions occurred in the patients studied.
Original language | English (US) |
---|---|
Pages (from-to) | 1729-1731 |
Number of pages | 3 |
Journal | JAMA: The Journal of the American Medical Association |
Volume | 236 |
Issue number | 15 |
DOIs | |
State | Published - Oct 11 1976 |